Sysmex Corporation (HQ: Kobe, Japan: Chairman and CEO: Hisashi Ietsugu), the Foundation for Biomedical Research and Innovation at Kobe1 (Location: Kobe, Japan; President: Tasuku Honjo) and Kyoto University (Location: Kyoto, Japan; President: Juichi Yamagiwa) have begun joint research related to the Drug Discovery Innovation Program2: Developing Technologies for Diagnosing Immunological Diseases, which the Foundation is promoting. [...]

Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery   Emeryville, Calif.  Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that it has entered into a collaboration with ChemPartner Co., Ltd. (ChemPartner) focused on accelerating ChemPartner’s monoclonal antibody (mAb) discovery workflow utilizing the Beacon®Optofluidic platform. The goal is to expand ChemPartner’s antibody discovery [...]

Porvair Sciences has introduced the JG Finneran 50-position stackable rack for 12mm vials and tubes. This new stackable rack is designed to hold 12mm vials and tubes in the optimum orientation for pipetting tasks. Available in blue, black and white as standard, the 50-position rack is securely stackable saving valuable bench space. Constructed from durable, chemically-resistant polypropylene the [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH (“Navigo”) for the advancement of exclusive novel affinity ligands used in monoclonal antibody (mAb) and non-mAb downstream purification processes. Under the terms of this agreement, Repligen and Navigo will co-develop a portfolio [...]

Already equipped with CAMECA Large Geometry Secondary Ion Microprobe (IMS 1280-HR model), a CAMECA SXFiveFE Electron Probe Microanalyzer and a Nu Plasma 1700 Multi Collection ICP-MS, the Key Laboratory of Isotope Geochemistry in Guangzhou Institute of Geochemistry, Chinese Academy of Science, under leadership of leadership of Prof. Yi-gang Xu just ordered a NanoSIMS 50L. The NanoSIMS will be installed near the large [...]

World-leading genomics cloud computing group builds clinical tool for cancer care in Ontario TORONTO - Ziliomics Inc., a start-up created by FACIT, received seed financing from the Prospects Oncology Fund. Derived from a leading oncology bio-computing group and leveraging insights from the world's largest cancer genomics projects, Ziliomics develops web-based, modular software platforms that help physicians make [...]

Menlo Park, CA and South Plainfield, NJ — Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leading provider of high-quality sequencing systems for genomes, transcriptomes and epigenomes, and GENEWIZ, a leading global genomics service provider, today announced that Professor Dr. Arne Nolte of the Institute for Biology and Environmental Sciences at the University of Oldenburg, Germany and Assistant [...]

Newswise — PITTSBURGH – UPMC and the University of Pittsburgh today announced the launch of an advanced genome sequencing center to support clinical diagnostics and research initiatives in precision medicine and immunotherapy. The UPMC Genome Center, established with funding from the recently announced UPMC Immune Transplant and Therapy Center (ITTC) and the Institute for Precision Medicine at UPMC and Pitt, will provide clinicians and researchers [...]

Program will Aim to Further Characterize the Functional Impact of Nektar Immunotherapies BRANFORD, Conn. -- IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today its collaboration with Nektar Therapeutics. The collaboration is focused on further defining the functional impact of NKTR-214 in the clinic, at the single-cell level, [...]

Validated tissue bank and pre-collected immuno-oncology datasets speed up investigative research projects through to clinical development MINNEAPOLIS -- Bio-Techne has added new capabilities and options to its Advanced Cell Diagnostics(ACD)-branded RNAscope® and BaseScope™ in situ hybridization (ISH) Assay Services Portfolio to improve biotech and pharma discovery timelines and costs. Responding to customer needs, the company has expanded its pre-validated tissue bank with [...]